Get to Know Priscilla Alicea: Beauty Launchpad 25 Under 50K Winner for 2024
Beauty Launchpad
SEPTEMBER 27, 2024
Meet Priscilla Alicea (@thy_stylist). She is a master stylist and salon suite owner of Thy Stylist Hair Artistry in Old Bridge, NJ.
Fri.Sep 27, 2024
98 
Signs that it's Time to Expand Your Salon: A Comprehensive Guide
Salon Today
SEPTEMBER 27, 2024
As a salon owner, it's crucial to know when it's time to expand your business. In this guide, we'll explore key signs that indicate your salon is ready for growth, helping you make informed decisions about taking your business to the next level. Whether it's expanding your space, adding new services, or opening more locations, recognizing the right time to expand can be crucial for your salon's success.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Olivia Garden to Donate 50% of Proceeds from 2024 Breast Cancer Awareness Collection to Breast Cancer Research Foundation
Beauty Launchpad
SEPTEMBER 27, 2024
Olivia Garden, a leader in the professional and consumer hair care space, announces the launch of its 14th Annual Breast Cancer Awareness Special Edition Collection.
11 Trends in Beauty: Skinification of Sun, Collagen Everything, Biomimic Foundation and More
MedEsthetics
SEPTEMBER 27, 2024
C&T's "Consumer Pulse" series on the socials highlights the latest emerging searches and hashtags related to cosmetics. Here, we expand on those themes. This edition includes: Princess Cosmetics and the skinification of sun care, collagen everything, etc.
Exclusive Sneak Peek: Epicutis To Drop New Brightening Treatment
The Dermatology Digest
SEPTEMBER 27, 2024
Epicutis is launching its Arctigenin Brightening Treatment in October 2024, and the Dermatology Digest got an exclusive sneak peek of the serum. The new serum is powered by arctigenin, a patented extract from burdock seed, that is more stable than Vitamin C. That’s not the only property that sets it apart from Vitamin C. Arctigenin is also gentler and less likely to cause irritation and sensitivity.
The Weekly Roundup: September 23-27
Dermatology Times
SEPTEMBER 27, 2024
In case you missed it, this week we had news about bimekizumab's FDA approval for psoriatic arthritis, the acceptance of roflumilast foam's sNDA for scalp and body psoriasis, exclusive interviews from EADV 2024, and more.
Sign up to get articles personalized to your interests!
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
More Trending
Melinda Gooderham, MSc, MD, FRCPC: Insights Into Lebrikizumab’s Sustained 3-Year Efficacy
Dermatology Times
SEPTEMBER 27, 2024
Gooderham reviews key highlights from EADV 2024 on the ADjoin long-term extension trial for patients with moderate to severe AD.
Benzene in your products, Part 2: The story of Valisure
Lab Muffin Beauty Science
SEPTEMBER 27, 2024
Here’s Part 2 of our deep dive into benzene contamination in your products. In Part 1, we talked about whether the experiments were “realistic” (no), and whether the cancer risk was described accurately (also no). This time, we’ll be discussing the wider issues around the private lab behind these findings, Valisure. This is adapted from the video version (which works.
Post Hoc Analysis of Vilobelimab in Hidradenitis Suppurativa Suggests Clinically Meaningful Benefits
Dermatology Times
SEPTEMBER 27, 2024
Researchers reported reductions in draining tunnels and total lesion counts.
Deucravacitinib (Sotyktu) Meets Main Goals in Phase 3b/4 Scalp PsO Study
The Dermatology Digest
SEPTEMBER 27, 2024
More than three times as many patients with scalp psoriasis taking deucravacitinib ( Sotyktu , BMS) were clear or almost clear by Week 16 when compared to their counterparts in the placebo arm, according to data from the Phase 3b/4 PSORIATYK SCALP trial. Specifically, 48.5% people taking the oral tyrosine kinase 2 (TYK2) inhibitor showed a statistically significant improvement in the scalp-specific Physician’s Global Assessment (ss-PGA) response of 0 or 1 (clear/almost clear) at 16 weeks.
Deuruxolitinib Shows Efficacy in Hair Regrowth, Patient Satisfaction, and Psychosocial Wellbeing in Severe Alopecia Areata
Dermatology Times
SEPTEMBER 27, 2024
Arash Mostaghimi, MD, MPH, MPA, provides insights into what clinicians need to know about deuruxolitinib for severe AA.
LEO Pharma Presents Extensive Data at EADV
Dermatology Times
SEPTEMBER 27, 2024
Key highlights of the presentations included data on delgocitinib for atopic hand eczema, and tralokinumab for head and neck atopic dermatitis.
Management of Plaque Psoriasis in a 45-year-old Woman via Telemedicine
Dermatology Times
SEPTEMBER 27, 2024
E. James Song, MD, FAAD, presents the case of a 45-year-old woman with plaque psoriasis who lives in a rural area, introducing a discussion on clinical telemedicine practices.
Role of PDE-4 in the Management of Plaque Psoriasis
Dermatology Times
SEPTEMBER 27, 2024
Focusing on treatment paradigms in plaque psoriasis, E. James Song, MD, FAAD, provides insights on phosphodiesterase inhibitors 4 (PDE-4) and their role in the therapeutic landscape.
Let's personalize your content